Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

51 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-05-31

Study Completion Date

2010-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to explore the concept of GnRH-agonist triggering in combination with elective cryopreservation of all 2PN oocytes at larger scale in a pragmatic clinical setting. The question asked is: "Does GnRH-agonist triggering and cryopreservation work", in terms of efficacy and safety, when applied to a larger cohort of patients, and by a number of different centres with different clinical routines.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Use of GnRH Agonist Trigger in the Prevention of OHSS

NCT00349258

Ovarian Hyperstimulation Syndrome

COMPLETED PHASE4

Ovarian Response in Oocyte Donors Triggered With GnRH Agonists

NCT05109403

Poor Response to Ovulation Induction

COMPLETED

Freeze All Strategy Versus Fresh Embryo Transfer After GnRH Analogue Trigger

NCT05362734

Ovarian Hyperstimulation Syndrome Pregnancy Related

COMPLETED

Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS

NCT02200952

Ovarian Hyperstimulation Syndrome

COMPLETED

Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response

NCT02701452

Ovarian Hyperstimulation Syndrome Hypercoagulability

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ovarian Hyperstimulation Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

OHSS risk

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Indication for IVF with ICSI
* Age \< 40 years
* \< 4 failed previous IVF attempts with embryo transfer
* ovarian stimulation with GnRH-antagonist and gonadotrophins
* \>20 follicles \>11 mm in mean diameter or E2 \>4500 pg/ml on the day , on which it was planned to administer hCG
* willing to participate and able to consent
* patient has not previously received GnRH-agonist as a trigger of final oocyte maturation